Xiangyu Medical Co. Ltd. A (688626): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 36,97 Renminbi Yuan | 94,652 Renminbi Yuan | 36,42 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 63 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 160.000.000 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 767.747,4 | 743.531,309 | 744.810,202 | 488.529,43 | 523.496,223 | 495.513,744 | 427.414,97 | 358.857,506 | 289.135,948 |
Cashflow aus operativer Geschäftstätigkeit | 189.816,78 | 178.594,439 | 227.908,629 | 186.703,174 | 165.880,603 | 216.403,459 | 155.943,755 | 74.199,04 | 59.312,942 |
▸ Operative Cashflow Marge | 24,72% | 24,02% | 30,6% | 38,22% | 31,69% | 43,67% | 36,49% | 20,68% | 20,51% |
Investitionsausgaben (CapEx) | 287.183,039 | 438.890,636 | 479.260,831 | 203.073,469 | 133.910,02 | 139.713,728 | 21.065,936 | 7.015,696 | 14.844,827 |
Cashflow aus Investitionstätigkeit | - | -275.755,021 | -234.542,777 | -178.904,95 | -782.041,152 | -139.409,655 | 189.129,067 | -136.733,525 | -117.802,076 |
Cashflow aus Finanzierungstätigkeit | - | 148.378 | -58.502,462 | -117.043,672 | 955.128,158 | 48.186,189 | -2.685,335 | 63.343,317 | 56.373,735 |
Freier Cashflow | -97.366,259 | -260.296,197 | -251.352,202 | -16.370,295 | 31.970,583 | 76.689,731 | 134.877,819 | 67.183,344 | 44.468,115 |
▸ Freie Cashflow Marge | -12,68% | -35,01% | -33,75% | -3,35% | 6,11% | 15,48% | 31,56% | 18,72% | 15,38% |
Ausgeschüttete Dividenden | -44.434,165 | -85.590,792 | -40.457,56 | -59.935,696 | -59.200 | -805,764 | - | -34,441 | -101.048,165 |
Neuausgabe und Rückkäufe von Stammaktien | - | -77.572,236 | -25.661,263 | -73.270,345 | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.